Your browser doesn't support javascript.
loading
Vaccine Derived Poliovirus (VDPV).
Mohanty, Aroop; Rohilla, Ranjana; Zaman, Kamran; Hada, Vivek; Dhakal, Surakchhya; Shah, Abhishek; Padhi, Bijaya Kumar; Al-Qaim, Zahra Haleem; Altawfiq, Kauthar Jaffar A; Tirupathi, Raghavendra; Sah, Ranjit; Al-Tawfiq, Jaffar A.
Afiliação
  • Mohanty A; Department of Microbiology, AIIMS Gorakhpur, Uttar Pradesh, India.
  • Rohilla R; Department of Microbiology, Shree Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India.
  • Zaman K; Department of Microbiology and Molecular Biology, ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka, India.
  • Hada V; Department of Microbiology, AIIMS Gorakhpur, Uttar Pradesh, India.
  • Dhakal S; Department of Medicine, Nepal Medical College and teaching hospital, Dharan, Nepal.
  • Shah A; Department of Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
  • Padhi BK; Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, India.
  • Al-Qaim ZH; Department of Anesthesia techniques, Al-Mustaqbal University College, Hillah, Babylon, Iraq.
  • Altawfiq KJA; Department of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Tirupathi R; Internal Medicine Department, Keystone Health, Chambersburg, USA.
  • Sah R; Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
  • Al-Tawfiq JA; Dr. D.Y Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
Infez Med ; 31(2): 174-185, 2023.
Article em En | MEDLINE | ID: mdl-37283637
Poliomyelitis is caused by Poliovirus, a member of a large group of enteroviruses. Vaccine-derived polioviruses (VDPVs) stem from mutated live poliovirus, which is contained in the Oral Polio Virus vaccine (OPV). In addition, the emergence of VDPV is one of the global challenges for the eradication of poliomyelitis. VDPVs continue to affect different parts of the world; 1081 cases occurred in 2020 and 682 cases in 2021. There are several reasons that may have caused the increase in circulating vaccine-derived poliovirus (cVDPV) after the "switch" from the trivalent to the bivalent oral polio vaccine. One reason is the low vaccination rate among the targeted population, which has been further aggravated by the COVID-19 pandemic. Several strategies could control the spread of VDPV including the use of the monovalent OPV (mOPV-2). The risk of VDPV can be minimized through increased immunization rates and the use of safer vaccine alternatives. The global effort to eradicate polio has made significant progress over the years, but continued vigilance and investment in immunization programs are needed to achieve the ultimate goal of a polio-free world.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infez Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infez Med Ano de publicação: 2023 Tipo de documento: Article